Pfizer animal health IPO could raise more than $2B
January 18, 2013 @ 7:24 am
NEW YORK (AP) - Drugmaker Pfizer Inc., which is spinning off its animal health business through an initial public offering, intends to sell 86.1 million shares of common stock.
New York-based Pfizer estimates the price for shares of the unit, called Zoetis (zoh-EHT'-ihs) Inc., at $22 to $25. At those prices, the IPO would raise $1.89 billion to $2.15 billion.
The business, which sells vaccines and medicines for pets and farm animals, had 2011 revenue of $4.2 billion.
That makes it the world's largest animal health business, according to a prospectus Pfizer filed with the Securities and Exchange Commission. It notes Zoetis products are sold in more than 120 countries, in five major product categories.
The unit's spinoff is part of efforts by Pfizer CEO Ian Read to revamp the world's largest drugmaker.
(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
-

Heartstopping
Daredevils post breathtaking pictures atop Seattle landmarks -

Snowy Passes
Escape cold Seattle; go skiing at Crystal Mountain -

Dirty Wars
Director Jeremy Scahill says Obama hasn't been fighting a clean war
Bonneville Media encourages site users to express their opinions by posting comments. Our goal is to maintain a civil dialogue in which readers feel comfortable. At times, the comments can descend to personal attacks. Please do not engage in such behavior. We encourage your thoughtful comments which: have a positive and constructive tone, are on topic, are respectful toward others and their opinions. Bonneville reserves the right to remove comments which do not conform to these criteria.







